| Empagliflozin in acute myocardial infarction: the EMMY trial D von Lewinski, E Kolesnik, NJ Tripolt, PN Pferschy, M Benedikt, ... European heart journal 43 (41), 4421-4432, 2022 | 317 | 2022 |
| Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial A Bauer, M Schreinlechner, N Sappler, T Dolejsi, H Tilg, BA Aulinger, ... The Lancet Respiratory Medicine 9 (8), 863-872, 2021 | 122 | 2021 |
| Valvular heart disease in Parkinson's disease vs. controls: An echocardiographic study C Peralta, E Wolf, H Alber, K Seppi, S Müller, S Bösch, GK Wenning, ... Movement disorders: official journal of the Movement Disorder Society 21 (8 …, 2006 | 106 | 2006 |
| Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction—The EMMY trial NJ Tripolt, E Kolesnik, PN Pferschy, N Verheyen, K Ablasser, S Sailer, ... American Heart Journal 221, 39-47, 2020 | 88 | 2020 |
| The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria M Razpotnik, S Bota, P Wimmer, M Hackl, G Lesnik, H Alber, ... Liver International 41 (5), 1058-1069, 2021 | 80 | 2021 |
| Neopterin, CD4+ CD28− lymphocytes and the extent and severity of coronary artery disease HF Alber, C Duftner, M Wanitschek, J Dörler, M Schirmer, ... International journal of cardiology 135 (1), 27-35, 2009 | 61 | 2009 |
| Comparison of peripheral endothelial function in shift versus nonshift workers A Suessenbacher, M Potocnik, J Dörler, G Fluckinger, M Wanitschek, ... The American journal of cardiology 107 (6), 945-948, 2011 | 57 | 2011 |
| Gender-related outcome following percutaneous coronary intervention for ST-elevation myocardial infarction: data from the Austrian acute PCI registry A Suessenbacher, J Doerler, H Alber, J Aichinger, J Altenberger, ... EuroIntervention 4 (2), 271-6, 2008 | 57 | 2008 |
| Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease HF Alber, M Frick, A Süssenbacher, J Dörler, W Dichtl, EM Stocker, ... Wiener Medizinische Wochenschrift 157 (3), 73-78, 2007 | 56 | 2007 |
| High‐density lipoprotein cholesterol, C‐reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography HF Alber, MM Wanitschek, S De Waha, A Ladurner, A Suessenbacher, ... European journal of clinical investigation 38 (6), 372-380, 2008 | 55 | 2008 |
| Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease—a randomized, placebo … HF Alber, M Frick, A Suessenbacher, J Doerler, M Schirmer, EM Stocker, ... American heart journal 151 (1), 139. e1-139. e7, 2006 | 54 | 2006 |
| Chronic heart failure is associated with vascular remodeling of the brachial artery G Poelzl, M Frick, H Huegel, B Lackner, HF Alber, J Mair, M Herold, ... European journal of heart failure 7 (1), 43-48, 2005 | 54 | 2005 |
| Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls B Ezeh, M Haiman, HF Alber, B Kunz, B Paulweber, A Lingenhel, HG Kraft, ... Journal of lipid research 44 (8), 1523-1529, 2003 | 54 | 2003 |
| Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on … J Dulakk, A Józkowicz, W Dichtl, H Alber, SP Schwarzacher, O Pachinger, ... Atherosclerosis 159 (2), 325-332, 2001 | 53 | 2001 |
| Vascular endothelial growth factor (VEGF) plasma concentrations in coronary artery disease HF Alber, M Frick, J Dulak, J Dörler, RH Zwick, W Dichtl, O Pachinger, ... Heart 91 (3), 365-366, 2005 | 46 | 2005 |
| Effect of pre-hospital ticagrelor during the first 24 h after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: the … G Montalescot, AW van’t Hof, L Bolognese, WJ Cantor, A Cequier, ... JACC: Cardiovascular Interventions 9 (7), 646-656, 2016 | 45 | 2016 |
| Short‐and long‐term changes of flow‐mediated vasodilation in patients under statin therapy M Frick, HF Alber, H Hügel, SP Schwarzacher, O Pachinger, F Weidinger Clinical Cardiology: An International Indexed and Peer‐Reviewed Journal for …, 2002 | 44 | 2002 |
| Limited utilities of N-terminal pro B-type natriuretic peptide and other newer risk markers compared with traditional risk factors for prediction of significant angiographic … A Peer, G Falkensammer, H Alber, A Kroiss, A Griesmacher, H Ulmer, ... Heart 95 (4), 297-303, 2009 | 43 | 2009 |
| CYP2C19 phenoconversion by routinely prescribed proton pump inhibitors omeprazole and esomeprazole: clinical implications for personalized medicine M Klieber, H Oberacher, S Hofstaetter, B Beer, M Neururer, A Amann, ... The Journal of Pharmacology and Experimental Therapeutics 354 (3), 426-430, 2015 | 39 | 2015 |
| Is there a relation between non-calcifying coronary plaques and acute coronary syndromes? A retrospective study using multislice computed tomography G Feuchtner, T Postel, F Weidinger, M Frick, H Alber, W Dichtl, D Jodocy, ... Cardiology 110 (4), 241-248, 2008 | 39 | 2008 |
Hanno UlmerMedical University of InnsbruckVerified email at i-med.ac.at
